DNA encoded peptide library for SARS-CoV-2 3CL protease covalent inhibitor discovery and profiling

Yuyu Xing, Huiya Zhang, Yanhui Wang, Zhaoyun Zong, Matthew Bogyo and Shiyu Chen

RSC Chem. Biol., 2024, 5, 691
DOI: 10.1039/D4CB00097H

Chemistries of bifunctional PROTAC degraders

Chaoguo Cao, Ming He, Liguo Wang, Yuna He and Yu Rao

Chem. Soc. Rev., 2022, 51, 7066
DOI: 10.1039/D2CS00220E

Covalent cannabinoid receptor ligands – structural insight and selectivity challenges

Ian Liddle, Michelle Glass, Joel D. A. Tyndall and Andrea J. Vernall

RSC Med. Chem., 2022, 13, 497
DOI: 10.1039/D2MD00006G

Research progress of anticancer drugs targeting CDK12

Zhijia Yan, Yongli Du, Haibin Zhang, Yong Zheng, Huiting Lv, Ning Dong and Fang He

RSC Med. Chem., 2023, 14, 1629
DOI: 10.1039/D3MD00004D

Catalyst-free late-stage functionalization to assemble α-acyloxyenamide electrophiles for selectively profiling conserved lysine residues

Yuanyuan Zhao, Kang Duan, Youlong Fan, Shengrong Li, Liyan Huang, Zhengchao Tu, Hongyan Sun, Gregory M. Cook, Jing Yang, Pinghua Sun, Yi Tan, Ke Ding and Zhengqiu Li

Commun Chem, 2024, 7
DOI: 10.1038/s42004-024-01107-4

Computational Insights into Acrylamide Fragment Inhibition of SARS-CoV-2 Main Protease

Ping Chen, Liyuan Wu, Bo Qin, Haodong Yao, Deting Xu, Sheng Cui and Lina Zhao

CIMB, 2024, 46, 12847
DOI: 10.3390/cimb46110765

AI-driven covalent drug design strategies targeting main protease (m pro ) against SARS-CoV-2: structural insights and molecular mechanisms

Mohammad Hossein Haghir Ebrahim Abadi, Abdulrahman Ghasemlou, Fatemeh Bayani, Yahya Sefidbakht, Massoud Vosough, Sina Mozaffari-Jovin and Vladimir N. Uversky

Journal of Biomolecular Structure and Dynamics, 2025, 43, 5436
DOI: 10.1080/07391102.2024.2308769

Emerging strategies in lysine-targeted covalent inhibitor development: mechanisms and design advances

Bingjie Mao, Yan Zhang, Yingzhe Wang, Qidong You and Xiaoke Guo

Sci. Sin.-Chim, 2025
DOI: 10.1360/SSC-2025-0121

Slow-Binding and Covalent HDAC Inhibition: A New Paradigm?

Yasir S. Raouf and Carlos Moreno-Yruela

JACS Au, 2024, 4, 4148
DOI: 10.1021/jacsau.4c00828

Pinpointing Acidic Residues in Proteins

Weimin Xuan and Jun‐An Ma

ChemMedChem, 2024, 19
DOI: 10.1002/cmdc.202300623

Exploring the landscape of post-translational modification in drug discovery

Yuhao Cao, Tianyi Yu, Ziang Zhu, Yuanjiao Zhang, Shanliang Sun, Nianguang Li, Chunyan Gu and Ye Yang

Pharmacology & Therapeutics, 2025, 265, 108749
DOI: 10.1016/j.pharmthera.2024.108749

Species-Dependent Metabolism of a Covalent nsP2 Protease Inhibitor with In Vivo Antialphaviral Activity

Mohammad Anwar Hossain, Abigail K. Mayo, Anirban Ghoshal, Sharon Taft-Benz, Elizabeth Anderson, Noah L. Morales, Katia D. Pressey, Ava Vargason, Kim L. R. Brouwer, Nathaniel J. Moorman, Mark T. Heise and Timothy M. Willson

J. Med. Chem., 2025, 68, 10473
DOI: 10.1021/acs.jmedchem.5c00825

A temperature-regulated bioorthogonal reaction to target lysine: Hemiacetal pharmacophore in genipin irreversibly binds with UCP2, inhibiting mitochondrial thermogenesis

Fukui Shen, Wen Yang, Kaixue Zhang, Yanting Jiao, Jing Cui, Yuanyuan Hou and Gang Bai

Chinese Chemical Letters, 2023, 34, 108203
DOI: 10.1016/j.cclet.2023.108203

Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions

Ahmed M. Shawky, Faisal A. Almalki, Hayat Ali Alzahrani, Ashraf N. Abdalla, Bahaa G.M. Youssif, Nashwa A. Ibrahim, Mohammed Gamal, Hany A.M. El-Sherief, Maha M. Abdel-Fattah, Ahmed A. Hefny, Ahmed H. Abdelazeem and Ahmed M. Gouda

European Journal of Medicinal Chemistry, 2024, 277, 116704
DOI: 10.1016/j.ejmech.2024.116704

Targeted Covalent Inhibitors for Novel Therapeutics

Jingya Zhang, Wenshuo Gao, Yixia Wang, Junbiao Chang and Bin Yu

Future Med. Chem., 2023, 15, 1739
DOI: 10.4155/fmc-2023-0243

The expanding repertoire of covalent warheads for drug discovery

Namrashee V. Mehta and Mariam S. Degani

Drug Discovery Today, 2023, 28, 103799
DOI: 10.1016/j.drudis.2023.103799

Inhibitors of the Structural and Nonstructural Proteins of Alphaviruses

Damilohun Samuel Metibemu, Olawale Samuel Adeyinka, John Falode, Olamide Crown and Ifedayo Victor Ogungbe

ACS Infect. Dis., 2024, 10, 2507
DOI: 10.1021/acsinfecdis.4c00254

Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection

Lei Tian, Taotao Qiang, Xiuding Yang, Yue Gao, Xiaopei Zhai, Kairui Kang, Cong Du, Qi Lu, Hong Gao, Dezhu Zhang, Xiaolin Xie and Chengyuan Liang

European Journal of Medicinal Chemistry, 2024, 264, 115979
DOI: 10.1016/j.ejmech.2023.115979

Advancements, challenges, and future frontiers in covalent inhibitors and covalent drugs: A review

Muhammad Salman Hameed, Hongxuan Cao, Li Guo, Lei Zeng and Yanliang Ren

European Journal of Medicinal Chemistry Reports, 2024, 12, 100217
DOI: 10.1016/j.ejmcr.2024.100217

Covalent inhibitors possessing autophagy-modulating capabilities: charting novel avenues in drug design and discovery

Yutong Wang, Shiyu Luo, Hongbao Sun, Shuai Huang, Lianhai Shan and Jifa Zhang

Drug Discovery Today, 2025, 30, 104347
DOI: 10.1016/j.drudis.2025.104347

Application and Cross-Validation of a High-Throughput SPR Method for Characterizing Covalent Binding Ligands

Wei Zhou, Xuecheng Ye, Suraj Pandey and Xinlin Du

ACS Omega, 2025, 10, 29637
DOI: 10.1021/acsomega.5c03239

Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization

Veronica Di Sarno, Gianluigi Lauro, Simona Musella, Tania Ciaglia, Vincenzo Vestuto, Marina Sala, Maria Carmina Scala, Gerardina Smaldone, Francesca Di Matteo, Sara Novi, Mario Felice Tecce, Ornella Moltedo, Giuseppe Bifulco, Pietro Campiglia, Isabel M. Gomez-Monterrey, Robert Snoeck, Graciela Andrei, Carmine Ostacolo and Alessia Bertamino

European Journal of Medicinal Chemistry, 2021, 226, 113863
DOI: 10.1016/j.ejmech.2021.113863

Species-specific lipophilicities of fluorinated diketones in complex equilibria systems and their potential as multifaceted reversible covalent warheads

Ishay Columbus, Lee Ghindes-Azaria, Ido Michael Herzog, Eliav Blum, Galit Parvari, Yoav Eichen, Yoram Cohen, Eytan Gershonov, Eyal Drug, Sigal Saphier, Shlomi Elias, Boris Smolkin and Yossi Zafrani

Commun Chem, 2023, 6
DOI: 10.1038/s42004-023-01004-2

Covalent fragment approaches targeting non-cysteine residues

Noémi Csorba, Péter Ábrányi-Balogh and György M. Keserű

Trends in Pharmacological Sciences, 2023, 44, 802
DOI: 10.1016/j.tips.2023.08.014

Exploiting allosteric modulation: a new frontier for precision medicine

Esther Ugo Alum, Chidozie Dennis Udechukwu and David Chukwu Obasi

Mol Biol Rep, 2025, 52
DOI: 10.1007/s11033-025-10650-9

Pan-Transcriptional Enhanced Associated Domain Palmitoylation Pocket Covalent Inhibitor

Jinhyuk Kim, Hadong Kim, Jongwan Kim, Seon Yeon Cho, Sungho Moon, Youngki Yoo, Hanseong Kim, Jin Kwan Kim, Hyejin Jeon, Wan Namkung, Gyoonhee Han and Kyoung Tai No

J. Med. Chem., 2024, 67, 18957
DOI: 10.1021/acs.jmedchem.4c01393

A Comprehensive Guide for Assessing Covalent Inhibition in Enzymatic Assays Illustrated with Kinetic Simulations

Elma Mons, Sander Roet, Robbert Q. Kim and Monique P. C. Mulder

Current Protocols, 2022, 2
DOI: 10.1002/cpz1.419

Covalent Modification of the JH2 Domain of Janus Kinase 2

Sean P. Henry, Maria-Elena Liosi, Joseph A. Ippolito, Fabian Menges, Ana S. Newton, Joseph Schlessinger and William L. Jorgensen

ACS Med. Chem. Lett., 2022, 13, 1819
DOI: 10.1021/acsmedchemlett.2c00414

Bioactivation and reactivity research advances – 2022 year in review‡

Shuai Wang, Upendra A. Argikar, Lionel Cheruzel, Sungjoon Cho, Rachel D. Crouch, Deepika Dhaware, Carley J. S. Heck, Kevin M. Johnson, Amit S. Kalgutkar, Lloyd King, Joyce Liu, Bin Ma, Hlaing Maw, Grover P. Miller, Herana Kamal Seneviratne, Ryan H. Takahashi, Cong Wei and S. Cyrus Khojasteh

Drug Metabolism Reviews, 2023, 55, 267
DOI: 10.1080/03602532.2023.2244193

New techniques and strategies in drug discovery (2020–2024 update)

Qijie Gong, Jian Song, Yihui Song, Kai Tang, Panpan Yang, Xiao Wang, Min Zhao, Liang Ouyang, Li Rao, Bin Yu, Peng Zhan, Saiyang Zhang and Xiaojin Zhang

Chinese Chemical Letters, 2025, 36, 110456
DOI: 10.1016/j.cclet.2024.110456

Activity-based protein profiling guided new target identification of quinazoline derivatives for expediting bactericide discovery

Jiao Meng, Ling Zhang, Xinxin Tuo, Yue Ding, Kunlun Chen, Mei Li, Biao Chen, Qingsu Long, Zhenchao Wang, Guiping Ouyang, Xiang Zhou and Song Yang

Journal of Advanced Research, 2025, 74, 57
DOI: 10.1016/j.jare.2024.10.002

Development of a Highly Selective Ferroptosis Inducer Targeting GPX4 with 2-Ethynylthiazole-4-carboxamide as Electrophilic Warhead

Sunkai Gu, Guanyu Yang, Hongyuan Bian, Fan Yang, Yajing Zhang, Yanhong Huang, Rui Su, Huilian Zhang, Xiuchun Zhao, Jin Liu, Shuheng Huang, Ling Huang, Benxin Hou, Yong Rao and Congjun Xu

J. Med. Chem., 2025, 68, 3309
DOI: 10.1021/acs.jmedchem.4c02530

Monitoring of Propiolamide-Mediated Molecular Crosstalk between Ferroptosis and Apoptosis by Raman Spectroscopy

Jiaheng Yu, Li Song, Guangyang Xu, Wei Li, Shiyi Liu, Han Xie, Jinping Tang, Jinyu Zhu and Xiao Xia Han

Anal. Chem., 2025, 97, 5259
DOI: 10.1021/acs.analchem.4c06968

CovPDB: a high-resolution coverage of the covalent protein–ligand interactome

Mingjie Gao, Aurélien F A Moumbock, Ammar Qaseem, Qianqing Xu and Stefan Günther

Nucleic Acids Research, 2022, 50, D445
DOI: 10.1093/nar/gkab868

Two-Step Covalent Docking with Attracting Cavities

Mathilde Goullieux, Vincent Zoete and Ute F. Röhrig

J. Chem. Inf. Model., 2023, 63, 7847
DOI: 10.1021/acs.jcim.3c01055

Restoring susceptibility to β-lactam antibiotics in methicillin-resistant Staphylococcus aureus

Van T. Nguyen, Biruk T. Birhanu, Vega Miguel-Ruano, Choon Kim, Mayte Batuecas, Jingdong Yang, Amr M. El-Araby, Eva Jiménez-Faraco, Valerie A. Schroeder, Alejandra Alba, Neha Rana, Safaa Sader, Caitlyn A. Thomas, Rhona Feltzer, Mijoon Lee, Jed F. Fisher, Juan A. Hermoso, Mayland Chang and Shahriar Mobashery

Nat Chem Biol, 2025, 21, 482
DOI: 10.1038/s41589-024-01688-0

De Novo Rational design of peptide-based covalent inhibitors via mapping of complementary binding site residues – technical protocol and case study on KRASG12C and BTK481C

Ernest Oduro-Kwateng, Musab Ali, Ibrahim Oluwatobi Kehinde, Li Rao and Mahmoud E. S. Soliman

BMC Methods, 2025, 2
DOI: 10.1186/s44330-025-00021-y

Nitrogen Heterocycle Synthesis through Hydride Abstraction of Acyclic Carbamates and Related Species: Scope, Mechanism, Stereoselectivity, and Product Conformation Studies

Jenna L. Miller, Krishnan Damodaran and Paul E. Floreancig

Chemistry A European J, 2023, 29
DOI: 10.1002/chem.202302977

Amino-Based Probe for Natural Products with Covalent Binding Ability to Lysine and Mechanism of Action of Medermycin

Jiaxu Shang, Shupeng Yin, Jingjing Shen, Chao Gao, Weihong Wang, Ke Sun, Weiming Zhu and Peng Fu

Org. Lett., 2024, 26, 10129
DOI: 10.1021/acs.orglett.4c03803

Alkyne as a Latent Warhead to Covalently Target SARS-CoV-2 Main Protease

Chau Ngo, William Fried, Saba Aliyari, Joshua Feng, Chao Qin, Shilei Zhang, Hanjing Yang, Jean Shanaa, Pinghui Feng, Genhong Cheng, Xiaojiang S. Chen and Chao Zhang

J. Med. Chem., 2023, 66, 12237
DOI: 10.1021/acs.jmedchem.3c00810

Disintegrate (DIN) Theory Enabling Precision Engineering of Proteins

Preeti Chauhan, Ragendu V., Mohan Kumar, Rajib Molla, Unnikrishnan V. B. and Vishal Rai

ACS Cent. Sci., 2023, 9, 137
DOI: 10.1021/acscentsci.2c01455

Covalent penicillin-protein conjugates elicit anti-drug antibodies that are clonally and functionally restricted

Lachlan P. Deimel, Lucile Moynié, Guoxuan Sun, Viliyana Lewis, Abigail Turner, Charles J. Buchanan, Sean A. Burnap, Mikhail Kutuzov, Carolin M. Kobras, Yana Demyanenko, Shabaz Mohammed, Mathew Stracy, Weston B. Struwe, Andrew J. Baldwin, James Naismith, Benjamin G. Davis and Quentin J. Sattentau

Nat Commun, 2024, 15
DOI: 10.1038/s41467-024-51138-7

Targeted anticancer pre-vinylsulfone covalent inhibitors of carbonic anhydrase IX

Aivaras Vaškevičius, Denis Baronas, Janis Leitans, Agnė Kvietkauskaitė, Audronė Rukšėnaitė, Elena Manakova, Zigmantas Toleikis, Algirdas Kaupinis, Andris Kazaks, Marius Gedgaudas, Aurelija Mickevičiūtė, Vaida Juozapaitienė, Helgi B Schiöth, Kristaps Jaudzems, Mindaugas Valius, Kaspars Tars, Saulius Gražulis, Franz-Josef Meyer-Almes, Jurgita Matulienė, Asta Zubrienė, Virginija Dudutienė and Daumantas Matulis

eLife, 2024, 13
DOI: 10.7554/eLife.101401.3

Covalent Warheads Targeting Cysteine Residue: The Promising Approach in Drug Development

Fangjiao Huang, Xiaoli Han, Xiaohui Xiao and Jinming Zhou

Molecules, 2022, 27, 7728
DOI: 10.3390/molecules27227728

Synthesis, screening and validation of cysteine-reactive fragments as chikungunya virus protease inhibitors

Junming He, Henry Illingworth, Sven Ullrich, Pritha Ghosh, Jennifer Ton, Colin J. Jackson and Christoph Nitsche

Bioorganic & Medicinal Chemistry Letters, 2025, 122, 130176
DOI: 10.1016/j.bmcl.2025.130176

Rational Design Strategies in DNA‐Encoded Libraries for Drug Discovery

Xudong Wang, Linjie Li, Xuanjing Shen and Xiaojie Lu

Angew Chem Int Ed, 2025
DOI: 10.1002/anie.202511839

Cyclopropenone, Cyclopropeniminium Ion, and Cyclopropenethione as Novel Electrophilic Warheads for Potential Target Discovery of Triple-Negative Breast Cancer

Shumin Lv, Fang Xu, Youlong Fan, Ke Ding and Zhengqiu Li

J. Med. Chem., 2023, 66, 2851
DOI: 10.1021/acs.jmedchem.2c01889

Design of ROS-Triggered Sesquiterpene Lactone SC Prodrugs as TrxR1 Covalent Inhibitors for the Treatment of Non-Small Cell Lung Cancer

Hui Ren, Yu-Jue Wang, Xin-Ye Wang, Xiangyun Li, Zheng Han, Guxue Zhang, Liwei Gu, Ming Bai, Guo-Dong Yao, Qingbo Liu and Shao-Jiang Song

J. Med. Chem., 2025, 68, 3088
DOI: 10.1021/acs.jmedchem.4c02334

Discovery of Trypanosoma brucei inhibitors enabled by a unified synthesis of diverse sulfonyl fluorides

Brian S. Mantilla, Jack S. White, William R. T. Mosedale, Andrew Gomm, Adam Nelson, Terry K. Smith and Megan H. Wright

Commun Chem, 2024, 7
DOI: 10.1038/s42004-024-01327-8

Innovative design and potential applications of covalent strategy in drug discovery

Tianyong Tang, Jiaxiang Luo, Dan Zhang, Yang Lu, Wen Liao and Jifa Zhang

European Journal of Medicinal Chemistry, 2025, 284, 117202
DOI: 10.1016/j.ejmech.2024.117202

Extended Applications of Small-Molecule Covalent Inhibitors toward Novel Therapeutic Targets

Jesang Lee and Seung Park

Pharmaceuticals, 2022, 15, 1478
DOI: 10.3390/ph15121478

A general leaving group assisted strategy for synthesis of pentafluorosulfanyl allylic compounds

Hui-Yi Yang, Hai-Bao Du, Yong-Ping Bai, Ya-Hui Ding, Yi-Fan Ma, Gang Wu, Ning Zhang, Nathaniel K. Szymczak and Shuo Guo

Sci. Adv., 2025, 11
DOI: 10.1126/sciadv.adw8408

Identification of potential COVID-19 Mpro inhibitors through covalent drug docking, molecular dynamics simulation, and MMGBSA calculation

Mohammad Hossein Haghir Ebrahim Abadi, Fatemeh Bayani and Yahya Sefidbakht

Sci Rep, 2025, 15
DOI: 10.1038/s41598-025-05375-5

Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Murugesan Vanangamudi, Senthilkumar Palaniappan, Muthu Kumaradoss Kathiravan and Vigneshwaran Namasivayam

Viruses, 2023, 15, 1992
DOI: 10.3390/v15101992

Rational Design Strategies in DNA‐Encoded Libraries for Drug Discovery

Xudong Wang, Linjie Li, Xuanjing Shen and Xiaojie Lu

Angewandte Chemie, 2025
DOI: 10.1002/ange.202511839

Targeting PfCLK3 with Covalent Inhibitors: A Novel Strategy for Malaria Treatment

Skye B. Brettell, Omar Janha, Abbey Begen, Gillian Cann, Saumya Sharma, Niniola Olaniyan, Tamas Yelland, Alison J. Hole, Benazir Alam, Emily Mayville, Ross Gillespie, Michael Capper, David A. Fidock, Graeme Milligan, David J. Clarke, Andrew B. Tobin and Andrew G. Jamieson

J. Med. Chem., 2024, 67, 18895
DOI: 10.1021/acs.jmedchem.4c01300

Unleashing the Power of Covalent Drugs for Protein Degradation

Meng‐Jie Fu, Hang Jin, Shao‐Peng Wang, Liang Shen, Hong‐Min Liu, Ying Liu, Yi‐Chao Zheng and Xing‐Jie Dai

Medicinal Research Reviews, 2025, 45, 1045
DOI: 10.1002/med.22101

Design, synthesis and biological evaluation of aminopyrimidine derivatives bearing dihydroquinoxalinone as novel EGFRL858R/T790M kinase inhibitors against non-small-cell lung cancer

Liping Fu, Yu Cao, Jingbai Chen, Ruoyu He, Yanmei Zhao, Yaping Zhao, Jianjun Xi, Rangxiao Zhuang and Chongmei Tian

Med Chem Res, 2023, 32, 1130
DOI: 10.1007/s00044-023-03054-6

Multiscale calculations reveal new insights into the reaction mechanism between KRASG12C and α, β-unsaturated carbonyl of covalent inhibitors

Xiao Yan, Chuanhua Qu, Qin Li, Lei Zhu, Henry H.Y. Tong, Huanxiang Liu, Qin Ouyang and Xiaojun Yao

Computational and Structural Biotechnology Journal, 2024, 23, 1408
DOI: 10.1016/j.csbj.2024.03.027